158 related articles for article (PubMed ID: 23960441)
1. 15-hydroxyprostaglandin dehydrogenase in colorectal mucosa as a potential biomarker for predicting colorectal neoplasms.
Lee HJ; Yang DH; Ryu YM; Song M; Song HJ; Jung KW; Kim KJ; Ye BD; Byeon JS; Choi EK; Yang SK; Kim JH; Myung SJ
J Korean Med Sci; 2013 Aug; 28(8):1154-60. PubMed ID: 23960441
[TBL] [Abstract][Full Text] [Related]
2. Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD).
Fink SP; Yamauchi M; Nishihara R; Jung S; Kuchiba A; Wu K; Cho E; Giovannucci E; Fuchs CS; Ogino S; Markowitz SD; Chan AT
Sci Transl Med; 2014 Apr; 6(233):233re2. PubMed ID: 24760190
[TBL] [Abstract][Full Text] [Related]
3. β-catenin represses expression of the tumour suppressor 15-prostaglandin dehydrogenase in the normal intestinal epithelium and colorectal tumour cells.
Smartt HJ; Greenhough A; Ordóñez-Morán P; Talero E; Cherry CA; Wallam CA; Parry L; Al Kharusi M; Roberts HR; Mariadason JM; Clarke AR; Huelsken J; Williams AC; Paraskeva C
Gut; 2012 Sep; 61(9):1306-14. PubMed ID: 22082586
[TBL] [Abstract][Full Text] [Related]
4. Inflammation Modulation by Vitamin D and Calcium in the Morphologically Normal Colorectal Mucosa of Patients with Colorectal Adenoma in a Clinical Trial.
Gibbs DC; Fedirko V; Baron JA; Barry EL; Flanders WD; McCullough ML; Yacoub R; Raavi T; Rutherford RE; Seabrook ME; Bostick RM
Cancer Prev Res (Phila); 2021 Jan; 14(1):65-76. PubMed ID: 32917645
[TBL] [Abstract][Full Text] [Related]
5. 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer.
Thiel A; Ganesan A; Mrena J; Junnila S; Nykänen A; Hemmes A; Tai HH; Monni O; Kokkola A; Haglund C; Petrova TV; Ristimäki A
Clin Cancer Res; 2009 Jul; 15(14):4572-80. PubMed ID: 19584167
[TBL] [Abstract][Full Text] [Related]
6. Possible predisposition for colorectal carcinogenesis due to altered gene expressions in normal appearing mucosa from patients with colorectal neoplasia.
Petersen CH; Mahmood B; Badsted C; Dahlby T; Rasmussen HB; Hansen MB; Bindslev N
BMC Cancer; 2019 Jun; 19(1):643. PubMed ID: 31253108
[TBL] [Abstract][Full Text] [Related]
7. 15-PGDH is reduced and induces apoptosis and cell cycle arrest in gastric carcinoma.
Lou LH; Jing DD; Lai YX; Lu YY; Li JK; Wu K
World J Gastroenterol; 2012 Mar; 18(10):1028-37. PubMed ID: 22416177
[TBL] [Abstract][Full Text] [Related]
8. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha.
Otani T; Yamaguchi K; Scherl E; Du B; Tai HH; Greifer M; Petrovic L; Daikoku T; Dey SK; Subbaramaiah K; Dannenberg AJ
Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G361-8. PubMed ID: 16195422
[TBL] [Abstract][Full Text] [Related]
9. 15-PGDH expression as a predictive factor response to neoadjuvant chemotherapy in advanced gastric cancer.
Hu M; Li K; Maskey N; Xu Z; Peng C; Tian S; Li Y; Yang G
Int J Clin Exp Pathol; 2015; 8(6):6910-8. PubMed ID: 26261578
[TBL] [Abstract][Full Text] [Related]
10. 15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors.
Yan M; Myung SJ; Fink SP; Lawrence E; Lutterbaugh J; Yang P; Zhou X; Liu D; Rerko RM; Willis J; Dawson D; Tai HH; Barnholtz-Sloan JS; Newman RA; Bertagnolli MM; Markowitz SD
Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9409-13. PubMed ID: 19470469
[TBL] [Abstract][Full Text] [Related]
11. Effect of ginger root on cyclooxygenase-1 and 15-hydroxyprostaglandin dehydrogenase expression in colonic mucosa of humans at normal and increased risk for colorectal cancer.
Jiang Y; Turgeon DK; Wright BD; Sidahmed E; Ruffin MT; Brenner DE; Sen A; Zick SM
Eur J Cancer Prev; 2013 Sep; 22(5):455-60. PubMed ID: 23222413
[TBL] [Abstract][Full Text] [Related]
12. 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer.
Backlund MG; Mann JR; Holla VR; Buchanan FG; Tai HH; Musiek ES; Milne GL; Katkuri S; DuBois RN
J Biol Chem; 2005 Feb; 280(5):3217-23. PubMed ID: 15542609
[TBL] [Abstract][Full Text] [Related]
13. HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells.
Moore AE; Greenhough A; Roberts HR; Hicks DJ; Patsos HA; Williams AC; Paraskeva C
Carcinogenesis; 2009 Oct; 30(10):1796-804. PubMed ID: 19638428
[TBL] [Abstract][Full Text] [Related]
14. Role of 15-hydroxyprostaglandin dehydrogenase down-regulation on the prognosis of hepatocellular carcinoma.
Yang JE; Park E; Lee HJ; Kang HJ; Kim KM; Yu E; Lee D; Shim JH; Lim YS; Lee HC; Chung YH; Lee YS
Clin Mol Hepatol; 2014 Mar; 20(1):28-37. PubMed ID: 24757656
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of 15-hydroxyprostaglandin dehydrogenase by interleukin-1β from activated macrophages leads to poor prognosis in pancreatic cancer.
Arima K; Komohara Y; Bu L; Tsukamoto M; Itoyama R; Miyake K; Uchihara T; Ogata Y; Nakagawa S; Okabe H; Imai K; Hashimoto D; Chikamoto A; Yamashita YI; Baba H; Ishimoto T
Cancer Sci; 2018 Feb; 109(2):462-470. PubMed ID: 29224225
[TBL] [Abstract][Full Text] [Related]
16. Bile acids inhibit NAD+-dependent 15-hydroxyprostaglandin dehydrogenase transcription in colonocytes.
Miyaki A; Yang P; Tai HH; Subbaramaiah K; Dannenberg AJ
Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G559-66. PubMed ID: 19608733
[TBL] [Abstract][Full Text] [Related]
17. Inverse expression of prostaglandin E2-related enzymes highlights differences between diverticulitis and inflammatory bowel disease.
Dai L; King DW; Perera DS; Lubowski DZ; Burcher E; Liu L
Dig Dis Sci; 2015 May; 60(5):1236-46. PubMed ID: 25666316
[TBL] [Abstract][Full Text] [Related]
18. Suppression of invasive properties of colorectal carcinoma SW480 cells by 15-hydroxyprostaglandin dehydrogenase gene.
Li M; Xie J; Cheng L; Chang B; Wang Y; Lan X; Zhang D; Yin Y; Cheng N
Cancer Invest; 2008 Nov; 26(9):905-12. PubMed ID: 19034772
[TBL] [Abstract][Full Text] [Related]
19. miR-21-mediated regulation of 15-hydroxyprostaglandin dehydrogenase in colon cancer.
Monteleone NJ; Moore AE; Iacona JR; Lutz CS; Dixon DA
Sci Rep; 2019 Apr; 9(1):5405. PubMed ID: 30931980
[TBL] [Abstract][Full Text] [Related]
20. Chemopreventive Efficacy of the Cyclooxygenase-2 (Cox-2) Inhibitor, Celecoxib, Is Predicted by Adenoma Expression of Cox-2 and 15-PGDH.
Wang J; Cho NL; Zauber AG; Hsu M; Dawson D; Srivastava A; Mitchell-Richards KA; Markowitz SD; Bertagnolli MM
Cancer Epidemiol Biomarkers Prev; 2018 Jul; 27(7):728-736. PubMed ID: 29769213
[No Abstract] [Full Text] [Related]
[Next] [New Search]
